Smart Nanoarchitectures for Precision RNA Delivery: Harnessing Endogenous and Exogenous Stimuli in Cancer Treatment

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapeutics

Background:

• RNA therapy shows promise for cancer treatment by precisely regulating gene expression.
• Physiological barriers such as nuclease degradation, limited cellular uptake, and inefficient release hinder RNA delivery.
• Stimuli-responsive nanocarriers offer a solution to enhance RNA delivery and therapeutic outcomes.

Purpose of the Study:

• To review recent advancements in stimuli-responsive nanocarriers for RNA delivery in cancer therapy.
• To highlight the design principles and mechanisms of these intelligent nanocarrier systems.
• To explore the future clinical translation potential of stimuli-responsive RNA nanocarriers.

Main Methods:

• Review of recent scientific literature on stimuli-responsive nanocarriers for RNA delivery.
• Analysis of nanocarrier designs responding to endogenous/exogenous stimuli (pH, redox, enzymes, light, etc.).
• Emphasis on mechanisms enabling targeted delivery and controlled RNA release.

Main Results:

• Stimuli-responsive nanocarriers effectively overcome physiological barriers to RNA delivery.
• These systems facilitate targeted delivery and controlled release of RNA payloads.
• Advanced designs demonstrate improved therapeutic efficacy and reduced side effects in preclinical studies.

Conclusions:

• Stimuli-responsive nanocarriers are crucial for advancing RNA-based cancer therapies.
• Further research into their design and clinical translation is essential for therapeutic success.
• These intelligent delivery systems hold significant potential for future cancer treatment strategies.